Search

everythinglearnresearchcommunity

for

Search:↓

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

The treatment combination is effective and generally safe for lung cancer.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

The new drug delivery system effectively targets lung cancer cells.